Literature DB >> 8733500

Home assessment of peak inspiratory flow through the Turbohaler in asthmatic patients.

R J Meijer1, T W van der Mark, B J Aalders, D S Postma, G H Koëter.   

Abstract

BACKGROUND: The efficacy of dry powder inhalers depends on the patient's inspiratory flow. Drug delivery from the Turbohaler (Turbuhaler in some countries), a multidose powder inhaler, is optimal at flows of > 40 l/min. The aim of this study was to investigate the peak inspiratory flow that can be generated by asthmatic patients through the budesonide Turbohaler (PIFTBH) during maintenance treatment at home.
METHODS: Thirty asthmatic patients, consecutively recruited from the outpatient clinic, inhaled their maintenance dose of 800 (n = 16) or 1600 micrograms/day (n = 14) for two months or one month, respectively. The Turbohaler was connected to a modified Vitalograph Compact installed at home to obtain printed PIFTBH values for all inhalations. Peak expiratory flow (PEF) was measured twice daily.
RESULTS: Flows were remarkably constant with individual mean PIFTBH values ranging from 55 l/min to 95 l/min. Only 13 of the 5248 PIFTBH recordings taken at home (three patients) were < 40 l/min and all were > 30 l/min. Weekly mean morning PEF values ranged from 114 l/min to 733 l/min. PIFTBH values could not be accurately predicted from lung function parameters in individual patients.
CONCLUSIONS: In a group of stable asthmatic patients inspiratory flow rates rarely fell below the 40 l/min needed to operate a Turbohaler.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8733500      PMCID: PMC1090683          DOI: 10.1136/thx.51.4.433

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  6 in total

1.  Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler).

Authors:  T Engel; J H Heinig; F Madsen; K Nikander
Journal:  Eur Respir J       Date:  1990-10       Impact factor: 16.671

2.  Influence of inspiratory flow rate upon the effect of a Turbuhaler.

Authors:  S Pedersen; O R Hansen; G Fuglsang
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

3.  Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI.

Authors:  L Thorsson; S Edsbäcker; T B Conradson
Journal:  Eur Respir J       Date:  1994-10       Impact factor: 16.671

4.  The bronchodilator response from inhaled terbutaline is influenced by the mass of small particles: a study on a dry powder inhaler (Turbuhaler).

Authors:  G Persson; J E Wirén
Journal:  Eur Respir J       Date:  1989-03       Impact factor: 16.671

5.  Importance of the inhalation device on the effect of budesonide.

Authors:  L Agertoft; S Pedersen
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

6.  Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler.

Authors:  T Engel; J H Heinig; H J Malling; B Scharling; K Nikander; F Madsen
Journal:  Allergy       Date:  1989-04       Impact factor: 13.146

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.